Home › NDC Lookup › Ingredients › Glycerin › 00132-0075-50
Fleet Glycerin 2 g Suppository, 50 suppositories — NDC 00132-0075-50 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Fleet Glycerin 2 g Suppository, 50 suppositories — NDC 0132-0075-50 (Billing 00132-0075-50)

by C.B. Fleet Company, Inc. · 50 SUPPOSITORY in 1 JAR

This is a package of 50 suppositories of Fleet Glycerin 2 g Suppository from C.B. Fleet Company, Inc., marketed since Nov 1984 and currently FDA-listed.

NDC 00132-0075-50
🏷️ FDA NDC (as labeled) 0132-0075-50 billing pads the labeler segment with a zero
This package
Contains50 suppositories Pack sizes4 compare ↓
Product page 00132-0075-00 Also comes in: 12 suppositories 0132-0075-12 24 suppositories 0132-0075-24 100 suppositories 0132-0075-00
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

⚠️
Other active recalls for Glycerin (different manufacturers) — 4 · tap to view
These affect other manufacturers’ products for the same ingredient — not necessarily the exact NDC on this page.
Class II · Apr 27, 2026 — Lack of Assurance of Sterility: The recall is being initiated out of an abundance of caution following FDA observations noted during a recent inspection of Excelvision. (Oasis Medical, Inc.) · FDA recall D-0525-2026
Class II · Apr 20, 2026 — Lack of Assurance of Sterility (SCOPE HEALTH) · FDA recall D-0499-2026
Class II · Mar 25, 2026 — Lack of Assurance of Sterility (Preferred Pharmaceuticals, Inc.) · FDA recall D-0443-2026
Class II · Mar 3, 2026 — Lack of Assurance of Sterility (K.C. Pharmaceuticals, Inc) · FDA recall D-0411-2026
Each entry is an official FDA enforcement report — look up any recall number in the FDA recall database ↗

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 0132-0075-50
Product NDC 0132-0075
11-digit billing NDC 00132007550
NCPDP billing unit EA — each (per item)
RxCUI 104155
UNII PDC6A3C0OX
UPC 0301320079128
Application # M007
SPL Set ID 31778652-e60e-4098-8e90-3e4f56b5800c
Established class (EPC) Non-Standardized Chemical Allergen
Physiologic effect Increased Histamine Release; Cell-mediated Immunity; Increased IgG Production
Chemical class Allergens; Glycerol
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1984-11-01
Route RECTAL
Dosage form SUPPOSITORY
Substance GLYCERIN

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 46600010005215
GPI class Glycerin (Adult)
Quick answers
  • GPI-14 (Medi-Span): 46600010005215
  • RxCUI (RxNorm): 104155
Why two NDCs? The FDA registers this code as 0132-0075-50 — a 4-4-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the labeler segment → 00132-0075-50. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Non-Standardized Chemical Allergen class.

Pharmacologic class Non-Standardized Chemical Allergen
Drug family (ATC) Enemas, Other drugs for constipation
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

🧪 What is this product?

Fleet Glycerin is a rectal suppository containing glycerin, an OTC monograph product. Glycerin is commonly used in suppository form as an osmotic agent that softens stool and is typically used to help relieve occasional constipation. The suppository is inserted into the rectum where it works locally to increase water content in the stool and promote bowel movement.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 12 suppositories 24 suppositories 100 suppositories
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
00132-0075-00 0132-0075-00 Main listing 100 SUPPOSITORY in 1 JAR 1984-11-01 — Active
00132-0075-12 0132-0075-12 12 SUPPOSITORY in 1 JAR 1984-11-01 — Active
00132-0075-24 0132-0075-24 24 SUPPOSITORY in 1 JAR 1984-11-01 — Active
00132-0075-50 You're viewing this 50 SUPPOSITORY in 1 JAR 1984-11-01 — Active

You're viewing one of 4 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 50 suppositories — 50 suppository in 1 jar.
How does this package differ from NDC 00132-0075-12?
Both are Fleet Glycerin 2 g Suppository — the drug itself is identical. This page's package is the 50 suppositories one, while NDC 00132-0075-12 is the 12 suppositories package.
What NDC number is used to bill for this package of Fleet Glycerin 2 g Suppository?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Glycerin 2 g 70000-0572-01 Cardinal 25 suppositories $0.103 — Availability likely —
Glycerin 2 g 57237-0325-21 Rising 12 suppositories $0.217 — Availability likely —
Proctozone GMax 2 g 57237-0339-21 Rising 12 suppositories $0.217 — Availability likely —
Fleet 2 gthis 00132-0075-50 C.B. 50 suppositories — — FDA listed —
Walgreens Adult Glycerin Laxative 2 g 00363-0445-25 Walgreens 62.5 g — — FDA listed —
Glycerin 2 g 11822-3312-05 Rite 50 suppositories — — FDA listed —
Rite-Aid Glycerin Laxative 2 g 11822-9100-00 RITE 100 suppositories — — FDA listed —
Glycerin Laxative 2 g 13709-0322-01 NeilMed 25 capsules — — FDA listed —
Glycerin Laxative 2 g/2.5g 13709-0329-01 Neilmed 2.5 g — — FDA listed —
Glycerin 2 g 37808-0398-50 H 50 suppositories — — FDA listed —
Stratuscare Adult Glycerin 2 g 58980-0410-12 Stratus 12 suppositories — — FDA listed —
CVS Pharmacy Glycerin Laxative 2 g 59779-0109-50 CVS 50 suppositories — — FDA listed —
Glycerin 2 g 68016-0015-79 Chain 25 suppositories — — FDA listed —
Glycerin 2 g 69842-0724-10 CVS 100 suppositories — — FDA listed —
Bliss GVS 2 g 72701-0106-05 Bliss 100 suppositories — — FDA listed —
Glycerin 2 g 84415-0039-50 Everpharm 50 suppositories — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1984
On the market since
Nov 1984
📍
2026
Currently FDA-listed
42 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerC.B. Fleet Company, Inc.
FDA applicationM007 (OTC MONOGRAPH DRUG)
Labeler code00132
First marketedNov 1984
Product typeHuman Otc Drug
Portfolio23 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose
🎯 Indications and Usage 17 words ▾

Uses for relief of occasional constipation this product usually produces bowel movement in ¼ to 1 hour

⏱️ Dosage and Administration 61 words ▾

Directions Single Daily Dosage (per 24 hours) adults and children 6 years and over 1 suppository or as directed by a doctor children 2 to under 6 years use Fleet® Pedia-Lax™ Suppositories children under 2 years consult a doctor Insert suppository well up into rectum, to produce laxative action. Suppository is designed to dissolve only partially, which may not be noticeable.

⚠️ Warnings 114 words ▾

Warnings For rectal use only. Do not use laxative products when abdominal pain, nausea, or vomiting are present unless directed by a doctor. Ask a doctor before using any laxative if you have a sudden change in bowel habits lasting more than 2 weeks already used a laxative for more than 1 week When using this product rectal discomfort or burning sensation may occur.

Stop using this product and consult a doctor if you have rectal bleeding no bowel movement within 1 hour of using this product These symptoms may indicate a serious condition. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

🧪 Active Ingredient 8 words ▾

Active ingredient (in each suppository) Glycerin 2 g

🧪 Inactive Ingredients 13 words ▾

Inactive ingredients aloe vera leaf, edetate disodium, purified water, sodium hydroxide, stearic acid

🎯 Purpose 3 words ▾

Purpose Hyperosmotic laxative

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by C.B. Fleet Company, Inc.. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 3 other package presentations of this same product, including 12 suppositories (00132-0075-12), 24 suppositories (00132-0075-24), 100 suppositories (00132-0075-00). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
C.B. Fleet Company, Inc. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 00131-5410-70 · UCB, 00132-0078-01 · C.B. →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.